FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/03/050329 [Registered on: 03/03/2023] Trial Registered Prospectively
Last Modified On: 02/03/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) 
Study Design  Other 
Public Title of Study   To know the effect of guggulu and churna in the management of Amavata w.s.r. to Rheumatoid Arthritis 
Scientific Title of Study   A comparative clinical study to evaluate the effect of vatari guggulu and shatpushpadi churna with simhanada guggulu in the management of amavata w.s.r. to rheumatoid arthritis 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Professor Anjana Mishra 
Designation  M.D. ( ayu.) kayachikitsa department 
Affiliation  RGGPG AYURVEDIC COLLEGE PAPROLA H.P.. 
Address  Department of kayachikitsa room number 215 Rajiv Gandhi Govt Post Graduate Ayurvedic college Kangra HIMACHAL PRADESH 176115 INDIA

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418312324  
Fax    
Email  dranjana269@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Professor Anjana Mishra 
Designation  M.D. ( AYU) kayachikitsa department 
Affiliation  RGGPG AYURVEDIC COLLEGE PAPROLA H.P.. 
Address  Department of kayachikitsa room number 215 Rajiv Gandhi Govt Post Graduate Ayurvedic college Kangra HIMACHAL PRADESH 176115 INDIA

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418312324  
Fax    
Email  dranjana269@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Shivani 
Designation  PG Scholar 
Affiliation  RGGPG AYURVEDIC COLLEGE PAPROLA H.P.. 
Address  kayachikitsa department rajiv gandhi govt post graduate ayurvedic college and hospital paprola kangra HIMACHAL PRADESH 176115

Kangra
HIMACHAL PRADESH
176115
India 
Phone  6230405596  
Fax    
Email  thakurshivani9974@gmail.com  
 
Source of Monetary or Material Support  
Baijnath Pharmacy Paprola District Kangra Himachal Pradesh 
 
Primary Sponsor  
Name  Rajiv Gandhi Govt Post Graduate Ayrvedic College and Hospital Paprola 
Address  Rajiv Gandhi Govt Post Graduate Ayrvedic College and Hospital Paprola District Kangra Pin Code 176115 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Professor Anjana Mishra  Rajiv ghandhi govt post graduate ayurvedic college and hospital paprola  Department of kayachikitsa room number 215 Rajiv Gandhi Govt Post Graduate Ayurvedic college Kangra HIMACHAL PRADESH 176115 INDIA
Kangra
HIMACHAL PRADESH 
09418312324

dranjana269@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC (Human)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M059||Rheumatoid arthritis with rheumatoid factor, unspecified. Ayurveda Condition: AMAVATAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Simhanada guggulu, Reference: Chakardutt Aamvatadhikar/29-34, Route: Oral, Dosage Form: Guggulu , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 6 Weeks, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Vatari guggulu, Reference: Bhaishajya ratnavali 29/149-151, Route: Oral, Dosage Form: Guggulu , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 6 Weeks, anupAna/sahapAna: No, Additional Information: -
(2) Medicine Name: Shatpushpadi churna, Reference: Chakradutta amavatadhikara /21, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 6 Weeks, anupAna/sahapAna: Yes(details: -), Additional Information: -
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patient willing for study

Age group 30-70 years will be selected for the study

Patients with signs and symptoms of Amavatar wsr. to Rheumatoid Arthritis as described in classical texts and fulfill the diagnostic criteria.

 
 
ExclusionCriteria 
Details  1. Patients not willing for the study.

2. Patients below age of 30 years and above 70 years of age.

3. Patients suffering from cardiac, respiratory, P.T.B. Malignancy, Patient already taking chemotherapy, radiotherapy. Pregnant and Lactating women. Allergy to the research drug or any other condition considered to be Unfit for enrollment in the trial. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Relief in symptoms of amavata after intervention of vatari guggulu and shatpushpadi churna with simhanada guggulu

Morning stiffness
Generalised body aches
Reduced appetite
Thirst
Lethargy
Indigestion
Joints pain
Constipation
Disturbed sleep
Burning sensation
Nausea
 
6 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Improving quality of life  6 Weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   10/03/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Pateints will be selected from faculty/OPD of RGGPG Ayurvedic College and Hospital , Paprola . Two groups of 15 pateints will be selected on the basis of inclusion and exclusion criteria . Interventional drug will be given to both groups of patient to know the effect of Guggulu and churna 
Close